BDBM299922 6-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)pyridin-3- yl]oxy}methyl) piperidin-1-yl]-2- {[(1S)-2,2- difluoro- cyclopropyl] methoxy}-N- [(2R)-1- hydroxypropan-2- yl]pyrimidine-4- carboxamide::US9593097, Example 292
SMILES: C[C@H](CO)NC(=O)c1cc(nc(OC[C@@H]2CC2(F)F)n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1
InChI Key: InChIKey=AVQBKTCVHJNRGY-APWZRJJASA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase receptor UFO (Homo sapiens (Human)) | BDBM299922 (6-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.0330 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility... | US Patent US9593097 (2017) BindingDB Entry DOI: 10.7270/Q2GM89BD | |||||||||||
More data for this Ligand-Target Pair |